From: Burden of asthma and COPD overlap (ACO) in Taiwan: a nationwide population-based study
Medication typea | ACO cohort (N = 22,328) | COPD only (N = 69,648) | Asthma only (N = 50,293) | ||||||
---|---|---|---|---|---|---|---|---|---|
 | Total cost (USD) | Number of patients | Mean cost/person (USD) | Total cost (USD) | Number of patients | Mean cost/person (USD) | Total cost (USD) | Number of patients | Mean cost/person (USD) |
Anti-IgE | 28,993 | < 5b |  | 2842 | < 5b |  | 61,397 | 6 | 10,233 |
ICS | 132,777 | 2482 | 53 | 116,536 | 2710 | 43 | 283,766 | 6136 | 46 |
LTRA | 329,286 | 2119 | 155 | 81,646 | 993 | 82 | 738,900 | 5659 | 131 |
LABA | 16,242 | 944 | 17 | 35,013 | 2023 | 17 | 16,909 | 1832 | 9 |
ICS/LABA | 2,224,844 | 7820 | 285 | 1,582,052 | 7732 | 205 | 2,465,128 | 12,579 | 196 |
LAMA | 742,647 | 2125 | 349 | 1,497,123 | 4826 | 310 | 110,641 | 488 | 227 |
SABA | 276,888 | 9731 | 28 | 461,267 | 22,227 | 21 | 222,497 | 15,299 | 15 |
SAMA | 86,336 | 2974 | 29 | 181,629 | 8179 | 22 | 54,971 | 3900 | 14 |
SABA/SAMA (SABD) | 319,419 | 5758 | 55 | 653,839 | 14,720 | 44 | 181,868 | 6228 | 29 |
Systemic β2-agonist injection | 6 | 20 | 0.3 | 34 | 62 | 1 | 15 | 48 | 0.3 |
Systemic β2-agonist oral | 241,131 | 15,384 | 16 | 444,653 | 41,179 | 11 | 194,135 | 35,419 | 5 |
Systemic corticosteroids injection (≤14 days) | 223,498 | 8794 | 25 | 480,051 | 24,662 | 19 | 197,142 | 12,936 | 15 |
Systemic corticosteroids injection (>14Â days) | 43,054 | 719 | 60 | 96,799 | 1745 | 55 | 33,618 | 619 | 54 |
Systemic corticosteroids oral (≤14 days) | 18,951 | 10,480 | 2 | 34,385 | 26,126 | 1 | 30,325 | 23,742 | 1 |
Systemic corticosteroids oral (>14Â days) | 62,043 | 8620 | 7 | 97,912 | 16,564 | 6 | 61,374 | 13,994 | 4 |
Xanthine injection | 3469 | 2611 | 1 | 4517 | 4629 | 1 | 2102 | 2894 | 1 |
Xanthine oral | 295,758 | 17,934 | 16 | 483,469 | 49,230 | 10 | 217,083 | 37,405 | 6 |
Xanthine unknown | 2 | 6 | 0.3 | 0.4 | 8 | 0.1 | 0 | 5 | 0.0 |